1.14.99.29: deoxyhypusine monooxygenase
This is an abbreviated version!
For detailed information about deoxyhypusine monooxygenase, go to the full flat file.
Word Map on EC 1.14.99.29
-
1.14.99.29
-
eif-5a
-
spermidine
-
hypusine-containing
-
gc7
-
mimosine
-
ciclopirox
-
nepsilon-4-amino-2-hydroxybutyllysine
-
drug development
-
deferiprone
-
eif5a-1
-
polyamine-derived
-
4-aminobutyl
-
diiron
-
n1-guanyl-1,7-diaminoheptane
-
heat-repeats
-
heat-like
-
peroxo
-
deoxyhypusine-containing
-
medicine
- 1.14.99.29
-
eif-5a
- spermidine
-
hypusine-containing
- gc7
- mimosine
- ciclopirox
-
nepsilon-4-amino-2-hydroxybutyllysine
- drug development
- deferiprone
-
eif5a-1
-
polyamine-derived
-
4-aminobutyl
-
diiron
- n1-guanyl-1,7-diaminoheptane
-
heat-repeats
-
heat-like
-
peroxo
-
deoxyhypusine-containing
- medicine
Reaction
Synonyms
deoxyhypusine hydroxylase, deoxyhypusine hydroxylase homologue nero, deoxyhypusine synthase/hydroxylase, deoxyhypusyl hydroxylase, DOHH, DOOH, hDOHH, Lia1, More, nero, oxygenase, deoxyhypusine di-
ECTree
Advanced search results
Application
Application on EC 1.14.99.29 - deoxyhypusine monooxygenase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
drug development
medicine
-
eIF5A and the hypusine biosynthetic enzymes are potential targets for intervention in aberrant cell proliferation
drug development
-
eIF5A and the hypusine biosynthetic enzymes are potential targets for intervention in aberrant cell proliferation
drug development
-
eIF5A and the hypusine biosynthetic enzymes are potential targets for intervention in aberrant cell proliferation
drug development
-
eIF5A and the hypusine biosynthetic enzymes are potential targets for intervention in aberrant cell proliferation
drug development
-
eIF5A and the hypusine biosynthetic enzymes are potential targets for intervention in aberrant cell proliferation
drug development
-
eIF5A and the hypusine biosynthetic enzymes are potential targets for intervention in aberrant cell proliferation
drug development
-
the parasite enzyme is a potential target for antimalaria drug design
medicine
-
inhibition of DOHH leads to a decrease of hypusine-containing eIF5A and inhibition of eukaryotic cell growth, consequently, these results suggest that eIF5A and DOHH could be promising targets for antitumor and anti-HIV-1 therapies
medicine
-
the results support the concept that drugs targeting DOHH should be tested clinically for HIV-1 inhibition and could be developed as antiretrovirals